1l1v
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 1l1v |SIZE=350|CAPTION= <scene name='initialview01'>1l1v</scene> | |PDB= 1l1v |SIZE=350|CAPTION= <scene name='initialview01'>1l1v</scene> | ||
|SITE= | |SITE= | ||
| - | |LIGAND= | + | |LIGAND= <scene name='pdbligand=DA:2'-DEOXYADENOSINE-5'-MONOPHOSPHATE'>DA</scene>, <scene name='pdbligand=DC:2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE'>DC</scene>, <scene name='pdbligand=DG:2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE'>DG</scene>, <scene name='pdbligand=DT:THYMIDINE-5'-MONOPHOSPHATE'>DT</scene>, <scene name='pdbligand=DVA:D-VALINE'>DVA</scene>, <scene name='pdbligand=MVA:N-METHYLVALINE'>MVA</scene>, <scene name='pdbligand=PXZ:2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO-PHENOXAZIN-3-ONE'>PXZ</scene>, <scene name='pdbligand=SAR:SARCOSINE'>SAR</scene> |
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY= | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1l1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1l1v OCA], [http://www.ebi.ac.uk/pdbsum/1l1v PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1l1v RCSB]</span> | ||
}} | }} | ||
| Line 28: | Line 31: | ||
[[Category: perpendicular]] | [[Category: perpendicular]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:56:47 2008'' |
Revision as of 18:56, 30 March 2008
| |||||||
| Ligands: | , , , , , , , | ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
UNUSUAL ACTD/DNA_TA COMPLEX STRUCTURE
Overview
Many anticancer drugs interact directly with DNA to exert their biological functions. To date, all noncovalent, intercalating drugs interact with DNA exclusively by inserting their chromophores into base steps to form elongated and unwound duplex structures without disrupting the flanking base pairs. By using actinomycin D (ActD)-5'-GXC/CYG-5' complexes as examples, we have found a rather unusual interaction mode for the intercalated drug; the central Watson-Crick X/Y base pairs are looped out and displaced by the ActD chromophore. The looped-out bases are not disordered but interact perpendicularly with the base/chromophore and form specific H bonds with DNA. Such a complex structure provides intriguing insights into how ligand interacts with DNA and enlarges the repertoires for sequence-specific DNA recognition.
About this Structure
1L1V is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.
Reference
Looped out and perpendicular: deformation of Watson-Crick base pair associated with actinomycin D binding., Chou SH, Chin KH, Chen FM, Proc Natl Acad Sci U S A. 2002 May 14;99(10):6625-30. PMID:12011426
Page seeded by OCA on Sun Mar 30 21:56:47 2008
